Eris Lifesciences Ltd(NSE:ERIS)

{{price.price}} INR

{{price.change}}%

：{{price.high}}	：94274	：6.45%	：30.4936
：{{price.low}}	：130626054	：45.44%	：1910
：{{price.open}}	：-2.33%	：13.86%	：1097
：{{price.close}}	：1.78	：14372200000%	：188033796111

-5.74	-11.38	-13.28	-21.94
-8.66	13.39	125.03	126.78
5.25	4.37	2.84	94274
319416	895171	符号详情：1天涨跌率 -2.33	-4.63
-7.97	-33	-67	-120
1444	1447	1517	55628.1
62374.8	139460.8	133945.39	1.89
1.78	-0.41	0.76	1.89
0.43	0.24	1361	1361
1361	321	1097	1563
1740	1885	1910	1910
25.85	30.52	3518400000	4156500000
3834700000	13013500000	14372200000	9.63
8.82	25.82	30.49	7695800000
28936400000	29981600000
			7693800000
	23140900000	35034800000	9119700000
697500000	1997400000	747500000	2278300000
13911600000	37569400000	15228400000	15228400000
23888400000	71599600000	215297896111	252.49

			12.16
13.86	44.97	47.94	12.93
14.18	24.67	25.67

Eris Lifesciences Ltd. engages in the provision of pharmaceutical products. Its brands include Eritel, Glimsave, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The firm markets and distributes pharmaceutical drugs, such as tablets, syrups and injections. The company was founded by Amit Indubhushan Bakshi on January 25, 2007 and is headquartered in Ahmedabad, India.

： http://www.eris.co.in

：Amit Indubhushan Bakshi

：2007

：Ahmedabad

：Health technology

：Pharmaceuticals: major